---
$id: https://graph.org.ai/products/commodity/51142520
$type: Product
source: UNSPSC
code: "51142520"
title: "Budipine"
class: "51142500"
classTitle: "Antiparkinson drugs"
family: "51140000"
familyTitle: "Central nervous system drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Budipine

**UNSPSC Code**: 51142520
**Class**: [Antiparkinson drugs](Antiparkinson drugs.mdx)
**Family**: [Central nervous system drugs](../Central nervous system drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a cation channel blocker and antiparkinsonian agent with the molecular formula C21H27N, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier L9026OPI2Z, chemically known as 1-tert-butyl-4,4-diphenylpiperidine but generally known as budipine, which bears US NIH Compound Identifier 68778. Budipine most often comes in base and hydrochloride forms. European Medicines Agency schedules Budipine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05956MIG. The term BUDIPINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 31, No10, 1977, List 17). World Health Organization schedules budipine in its Anatomical Therapeutic Chemical (ATC) Classification. BUDIPINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule budipine under HS 29333999 and SITC 51574. As of Q4 2014, BUDIPINE remains the US FDA Preferred Term for this commodity. Budipine bears US NLM identifiers UMLS ID C0054202 and NCI Concept Code C73271. SMILES: N1(CCC(CC1)(C1CCCCC1)C1CCCCC1)C(C)(C)C.

